Michele L. Forster

FDA investigator

Appears on 9 documents from 2010 to 2018, most often at sites in Michigan. Most often cites written procedures; deviations (21 CFR 211.100).

9
Documents on file
6.3
Observations per 483
2010
First seen
2018
Most recent

What they cite most

From 57 observations

Activity by year

2010: 1, 2012: 1, 2013: 1, 2014: 1, 2016: 1, 2017: 3, 2018: 1

Where

Michigan 4 · California 1 · Florida 1 · France 1 · Japan 1 · North Carolina 1

Is Michele L. Forster coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 ADMA Biologics Inc.Apr 12, 2018 · Boca Raton, Florida
483 Sanofi Winthrop IndustrieSep 27, 2017 · Marcy L Etoile, France
483 California Stem Cell Treatment Center/Cell Surgical NetworkJul 27, 2017 · Beverly Hills, California
483 UNIGEN INC.Jun 15, 2017 · GIFU, Japan
483 Patheon Manufacturing Services LLCNov 18, 2016 · Greenville, North Carolina
483 Central Admixture Pharmacy Services, Inc.Jun 25, 2014 · Livonia, Michigan
483 Form 483 · FEI 3010450840Nov 5, 2013 · South Lyon, Michigan

About this profile

What does Michele L. Forster inspect?

Michele L. Forster appears on 9 documents on file covering 9 sites, most often in Michigan.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.113 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michele L. Forster is dated Apr 12, 2018.